[2-amino-5-bromo-4-(3-(trifluoromethyl)phenyl)thiophen-3-yl]phenyl-methanone

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [2-amino-5-bromo-4-(3-(trifluoromethyl)phenyl)thiophen-3-yl]phenyl-methanone
• 英文别名: [2-Amino-5-bromo-4-(3-(trifluoromethyl)phenyl)thiophen-3-yl]phenyl methanone；[2-amino-5-bromo-4-[3-(trifluoromethyl)phenyl]thiophen-3-yl]-phenylmethanone
• 化学式: C₁₈H₁₁BrF₃NOS
• 分子量: 426.257
• InChiKey: BNBSJESRUXAAQX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  71.3
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  在 肼 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 以96%的产率得到[2-amino-5-bromo-4-(3-(trifluoromethyl)phenyl)thiophen-3-yl]phenyl-methanone
  参考文献：
  名称：

  [EN] A1 ADENOSINE RECEPTOR ALLOSTERIC ENHANCERS
  [FR] AMPLIFICATEURS ALLOSTÉRIQUES DES RÉCEPTEURS DE L'ADÉNOSINE A1

  摘要：

  本发明一般涉及化合物及其使用和制备方法。具体地，本发明涉及可能具有有用的治疗活性的化合物，用于治疗促进血管生成有益的疾病，这些化合物在治疗中的使用以及药物的制造，以及含有这些化合物的组合物。

  公开号：

  WO2009049362A1

文献信息

• [EN] A1 ADENOSINE RECEPTOR ALLOSTERIC ENHANCERS<br/>[FR] AMPLIFICATEURS ALLOSTÉRIQUES DES RÉCEPTEURS DE L'ADÉNOSINE A1
  申请人：UNIV MONASH

  公开号：WO2009049362A1

  公开（公告）日：2009-04-23

  The present invention relates generally to chemical compounds and methods for their use and preparation. In particular, the invention relates to chemical compounds which may possess useful therapeutic activity for treating conditions where the promotion of angiogensis (blood vessel formation) is beneficial, use of these compounds in therapy and the manufacture of medicaments as well as compositions containing these compounds.

  本发明一般涉及化合物及其使用和制备方法。具体地，本发明涉及可能具有有用的治疗活性的化合物，用于治疗促进血管生成有益的疾病，这些化合物在治疗中的使用以及药物的制造，以及含有这些化合物的组合物。
• 2-Amino-3-benzoylthiophene Allosteric Enhancers of A₁ Adenosine Agonist Binding:  New 3, 4-, and 5-Modifications
  作者：Henning Lütjens、Andrea Zickgraf、Heidi Figler、Joel Linden、Ray A. Olsson、Peter J. Scammells

  DOI：10.1021/jm020295m

  日期：2003.5.1

  2-Amino-3-aroylthiophenes are agonist allosteric enhancers (AE) at the A, adenosine receptor (A(1)AR). Here we report the syntheses of three kinds of novel 2-aminothiophenes and assays of their AE activity at the human A(1)AR (hA(1)AR), namely, (1) 2-amino-4,5-diphenylthiophene-3-carboxylates, 3a-h, (2) 2-amino-3-benzoyl-4,5-diphenylthiophenes, 7a-p, and (3) 2-amino-5-bromo-3-benzoyl-4-phenylthiophenes, 10a-h. An in vitro assay employing the A(1)AR agonist [I-125]ABA and membranes from CHO-K1 cells stably expressing the hA(1)AR measured an index of AE activity, the ability of a candidate AE to stabilize the agonist-A(1)AR-G protein ternary complex, scored as the percentage of ternary complex remaining after 10 min of dissociation initiated by CPX and GTPgammaS. The AE activity score of 2-amino-4,5-dimethyl-3-(3-trifluoromethylbenzoyl)thiophene (PD 81,723), which was 19%, served as a standard for comparison. Two 3-carboxythiophene 3-trifluoromethylbenzyl esters, 3d (49%) and 3f (63%), had substantial AE activity. The 3-(1-naphthoyl) substituent of 7e (52%) also supported AE activity. Compounds in series 3 tended to be more potent, 10a and 10c having scores of 91 and 80%, respectively. The activity of 2-amino-5-bromo-3-ethoxycarbonyl-4-(3-nitrophenyl)thiophene, 10h (26%), is an exception to the rule that a 3-ethoxycarbonyl substituent cannot support AE activity.
• 5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers
  作者：Luigi Aurelio、Heidi Figler、Bernard L. Flynn、Joel Linden、Peter J. Scammells

  DOI：10.1016/j.bmc.2007.10.065

  日期：2008.2.1

  Two series of 5-substituted 2-amino-4-(3-trifluoromethylphenyl)thiophenes were prepared and evaluated as allosteric enhancers at the A(1) adenosine receptor (A(1)AR). In the 3-benzoyl series, a 5-phenyl group was found to confer the greatest potency (9a: ED50 = 2.1 mu M, AE score = 18%). However, the analogue with no 5-substituent (6b: ED50 = 15.8 mu M, AE score = 77%) proved to be the most efficacious. In the 3-ethoxycarbonyl series, the 5-(4-chlorophenyl) analogue was clearly the most potent and efficacious (91: ED50 = 6.6 mu M, AE score = 57%). The antagonist activity of all compounds was measured using a [H-3]CPX competitive binding assay. (c) 2007 Elsevier Ltd. All rights reserved.